top of page
CVVT
Admin
More actions
Profile
Join date: Mar 14, 2025
Posts (46)
Oct 14, 2025 ∙ 3 min
Our researchers develop powerful bispecific inhibitor to combat a wide range of coronaviruses
Researchers from the InnoHK Centre for Virology, Vaccinology and Therapeutics (CVVT) and the Department of Microbiology, School of Clinical Medicine, LKS Faculty of Medicine of the University of Hong Kong (HKUMed), in collaboration with Sichuan University, have discovered a powerful bispecific inhibitor capable of combating all existing human-pathogenic coronaviruses, including those resistant to existing treatments like Paxlovid. This promising inhibitor, named TMP1, offers hope for more...
46
0
Sep 10, 2025 ∙ 1 min
CVVT Showcases Cutting-Edge Innovations at BIOHK2025
Join the Centre for Virology, Vaccinology, and Therapeutics (CVVT) as we unveil cutting-edge advancements in influenza vaccines, liver...
58
0
Aug 27, 2025 ∙ 4 min
CVVT and HKUMed develop innovative organoid-based platform for precise evaluation of antibody and vaccine efficacy, accelerating FDA application of organoid technology
A collaborative research team from CVVT and the Department of Microbiology at the School of Clinical Medicine within the LKS Faculty of...
64
0
bottom of page